Geneos Wealth Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$305K Sell
4,278
-996
-19% -$78.5K 0.01% 827
2025
Q4
$433K Sell
5,274
-20
-0.4% -$1.56K 0.01% 707
2025
Q3
$398K Sell
5,294
-1,646
-24% -$123K 0.01% 720
2025
Q2
$514K Buy
6,940
+2,294
+49% +$160K 0.01% 701
2025
Q1
$607K Buy
4,646
+2,143
+86% +$184K 0.01% 820
2024
Q4
$196K Buy
+2,503
New +$213K 0.01% 839

Other funds holding GEHC

Geneos Wealth Management's GEHC Position: Q1 2026 in Review

Geneos Wealth Management reduced its GE HealthCare (GEHC) stake by 19% in Q1 2026, selling an estimated $78.5K and leaving 4,278 shares worth $305K. The position accounts for 0.01% of the portfolio, ranked #827.

Geneos Wealth Management first reported a position in GEHC in Q4 2024 and has held it in 6 quarters since. The position peaked at $607K in Q1 2025. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Geneos Wealth Management held 4,278 shares of GE HealthCare worth $305K as of Q1 2026.
  • Geneos Wealth Management sold 996 GE HealthCare shares in Q1 2026, an estimated $78.5K.
  • GE HealthCare made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #827 holding.
  • Geneos Wealth Management first reported a position in GE HealthCare in Q4 2024 and has held it in 6 quarters since.
  • Geneos Wealth Management's GE HealthCare position peaked at $607K in Q1 2025.
  • 1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.